Latest News

Dr Michael Sherman on Harvard Pilgrim's Work With Value Frameworks
Michael Sherman, MD, chief medical officer at Harvard Pilgrim Health Care, discusses how Harvard Pilgrim uses value framework during formulary deliberations to help make decisions, despite the fact that they only cover certain disease states right now.
More work needs to be done before this discovery can be translated into a therapeutic solution, but researchers have gained insights into why some people become infected with a pathogen and others don't.
To avoid bias, the study did use aggressive titration protocols that might be found in a real-world setting. Still, patients using CGM saw greater reductions in A1C and more time in range.
High out-of-pocket (OOP) medical costs in survivors of childhood cancer can influence their treatment choices and care-related behavior, and ultimately affect their health outcomes, according to a study published in the Journal of Clinical Oncology.
A CDC study asked adolescents and adults about their contact lens practices and found that most reported engaging in at least 1 risky behavior.
As observers across the United States prepare to witness a rare solar eclipse this afternoon, ophthalmologists are making sure the importance of vision safety is not overshadowed by the excitement.
The FDA has approved Besponsa (inotuzumab ozogamicin) for treating adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
New report from America's Health Insurance Plans outlines how negative social determinants of health are being addressed by federal and state agencies.
Brian Marcotte on Employers' Understanding of ACOs
Employers understand what accountable care organizations are, but they need a better understanding of how they deliver value better than the market, explained Brian Marcotte, president and CEO of the National Business Group on Health
Among wealthy countries, the United States maintains the most substantial socioeconomic disparities in access to healthcare; however, these disparities were reduced when the Affordable Care Act (ACA) was implemented, according to a new study in Health Affairs.
Study assessed the patterns of care for biologic-dosing outliers and nonoutliers in patients with rheumatoid arthritis.
Podcast: This Week in Managed Care—Eliminating the CSR Payments, and Other Health News
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

From the Journals

The Hospital-in-Home program implemented at the Veterans Affairs Pacific Islands Health Care System in Honolulu, Hawaii, is associated with reduced costs with no compromise in quality.
Technology innovation drives expenditures. A Michigan Medicine, IBM, and AirStrip partnership demonstrates the hospital’s role in developing transformative technologies that deliver value.
In a multicenter cohort of patients with newly diagnosed pulmonary hypertension, increased risk for mortality among African Americans was no longer observed after adjusting for insurance status.
A community oncologist's perspective on the advantages and challenges with precision medicine.
A reaction to Institute for Clinical and Economic Review's value assessment framework by Eleanor M. Perfetto, PhD, MS, of The National Health Council.
Syapse improves patient outcomes by providing workflow solutions that enable cancer care providers to deliver precision medicine within their organization, Ken Tarkoff, the company's CEO, told Evidence-Based Oncology™.
Collaborating with diverse stakeholders, including the FDA and the Surveillance, Epidemiology, and End Results program, CancerLinQ continues its efforts to harness big data to rapidly improve the quality of care for people with cancer.
Genetic counselors (GCs) increasingly serve a variety of roles across the healthcare spectrum, including test utilization management. Our data show that utilizing the expertise of GCs reduced test order errors, improved patient outcomes, and resulted in significant cost savings to the healthcare system.
As we shift to the precision-medicine model of cancer care, it is essential to develop a scalable system that can deliver these care solutions in a patient-centered, economically sustainable way.
Compendia
Adult ADHD Compendium
COPD Compendium
Dermatology Compendium
Diabetes Compendium
GI Compendium
Immuno-oncology Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Pain Compendium
Rare Disease Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
Managed Care PODCAST
Formulary
Upcoming Partner Events
October 24-25, 2017
San Francisco, CA

Most Popular

AJMC Strategic Alliance

$vacMongoViewPlus$